The pan-cancer analysis of LRG1 and its potential role in kidney renal clear cell carcinoma.

Summary: Scientists have investigated a protein called LRG1 to see how it affects cancer. They found that in 18 different types of cancer, especially a specific kind of kidney cancer, levels of this protein are much higher than normal. When LRG1 levels are high, it usually signals that the disease is more aggressive. This happens because the genetic "switch" that normally controls the protein is stuck in the "on" position. High LRG1 helps tumors grow new blood vessels and survive in low-oxygen environments. However, knowing this is useful: doctors can use LRG1 levels to predict how a patient will do and determine if specific treatments, like immunotherapy or targeted drugs, might work better.